The FDA has posted 19 enforcement recalls from Surgify Medical Oy since 2025, none of them Class I (most serious). Most recent report: Jul 1, 2026.
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Potential for burr breakage, occurring during bi-portal endoscopic spinal surgery (BESS).
Firm name as filed with the FDA: “SURGIFY MEDICAL OY”. Related firm entities may file under separate names. Source: U.S. FDA openFDA device enforcement reports. Informational only — verify with the FDA before acting.